These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Antigenic variation of vibrio el Tor during an epidemic in Kivu. Colaert J; Goyens P; Schyns C Ann Soc Belg Med Trop; 1978 Dec; 58(4):357-8. PubMed ID: 754661 [No Abstract] [Full Text] [Related]
10. [Monoclonal antibodies to antigens of cholera vibrios of the Ogava serovar]. Burlakhova OS; Alekseeva LP; Novokhatskiĭ AS; Bichul' KG; Dranov IIu Mikrobiol Zh (1978); 1989; 51(3):56-60. PubMed ID: 2796789 [TBL] [Abstract][Full Text] [Related]
11. Identification of some antigenically related outer-membrane proteins of strains of Vibrio cholerae O1 and non-O1 serovars involved in intestinal adhesion and the protective role of antibodies to them. Sengupta D; Datta-Roy K; Banerjee K; Ghose AC J Med Microbiol; 1989 May; 29(1):33-9. PubMed ID: 2724325 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of terminal disaccharide elements corresponding to the Ogawa and Inaba antigenic determinant from Vibrio cholerae O1. Arencibia-Mohar A; Ariosa-Alvarez A; Madrazo-Alonso O; González Abreu E; García-Imia L; Sierra-González G; Verez-Bencomo V Carbohydr Res; 1998 Jan; 306(1-2):163-70. PubMed ID: 9691445 [TBL] [Abstract][Full Text] [Related]
14. Prophylactic significance of the nonlipopolysaccharide antigens of Vibrio cholerae. Attridge SR; Rowley D J Infect Dis; 1983 Nov; 148(5):931-9. PubMed ID: 6195273 [TBL] [Abstract][Full Text] [Related]
15. Immunochemical characterisation of Vibrio cholerae O139 O antigens and production of a diagnostic antiserum without absorption. Feodorova VA; Gromova OV; Devdariani ZL; Dzhaparidze MN; Teryoshkina NY J Med Microbiol; 2001 Jun; 50(6):499-508. PubMed ID: 11393287 [TBL] [Abstract][Full Text] [Related]
16. Immunity Provided by an Outer Membrane Vesicle Cholera Vaccine Is Due to O-Antigen-Specific Antibodies Inhibiting Bacterial Motility. Wang Z; Lazinski DW; Camilli A Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795359 [TBL] [Abstract][Full Text] [Related]
17. Crystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: molecular basis for serotype specificity. Villeneuve S; Souchon H; Riottot MM; Mazie JC; Lei P; Glaudemans CP; Kovác P; Fournier JM; Alzari PM Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8433-8. PubMed ID: 10880560 [TBL] [Abstract][Full Text] [Related]
18. Significance of toxin-coregulated pili as protective antigens of Vibrio cholerae in the infant mouse model. Sharma DP; Thomas C; Hall RH; Levine MM; Attridge SR Vaccine; 1989 Oct; 7(5):451-6. PubMed ID: 2573216 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and protective role of an IgA reactive 31-kDa antigen of Vibrio cholerae O139. Kumar S; Ray P; Singh H; Ganguly NK J Med Microbiol; 2001 Jun; 50(6):489-498. PubMed ID: 11393286 [TBL] [Abstract][Full Text] [Related]
20. Intraduodenal inoculation of adult rabbits for evaluating the immunogenicity of genetically attenuated Vibrio cholerae strains. García Imia L; Oliva Hernández R; Cedré Marrero B; Valmaseda Pérez T; García Sánchez H; Talavera Coronel A; Pérez Quiñoy JL; Sierra González G Lab Anim Sci; 1998 Oct; 48(5):538-41. PubMed ID: 10090073 [No Abstract] [Full Text] [Related] [Next] [New Search]